|
LDHA expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.77370000000021E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.258100E-03 |
| Normal-vs-Stage2 |
4.549900E-02 |
| Normal-vs-Stage3 |
1.316880E-03 |
| Normal-vs-Stage4 |
5.458500E-03 |
| Stage1-vs-Stage2 |
3.227400E-01 |
| Stage1-vs-Stage3 |
4.837600E-02 |
| Stage1-vs-Stage4 |
1.139500E-03 |
| Stage2-vs-Stage3 |
4.468600E-01 |
| Stage2-vs-Stage4 |
1.000030E-01 |
| Stage3-vs-Stage4 |
2.551000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.018300E-04 |
| Normal-vs-AfricanAmerican |
2.539700E-03 |
| Normal-vs-Asian |
1.727780E-01 |
| Caucasian-vs-AfricanAmerican |
5.957000E-01 |
| Caucasian-vs-Asian |
5.790400E-01 |
| AfricanAmerican-vs-Asian |
7.514000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.661900E-03 |
| Normal-vs-Female |
2.39329999995874E-06 |
| Male-vs-Female |
2.295400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.197700E-03 |
| Normal-vs-Extreme_Weight |
9.462200E-03 |
| Normal-vs-Obese |
6.392000E-04 |
| Normal-vs-Extreme_Obese |
8.938600E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.559030E-01 |
| Normal_Weight-vs-Obese |
8.594400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.633800E-02 |
| Extreme_Weight-vs-Obese |
7.612500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.455650E-01 |
| Obese-vs-Extreme_Obese |
1.567790E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.856100E-03 |
| Normal-vs-Age(41-60Yrs) |
6.16329999999499E-05 |
| Normal-vs-Age(61-80Yrs) |
8.895500E-03 |
| Normal-vs-Age(81-100Yrs) |
2.531800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.212950E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.345700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.012300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.214000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.932400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.442200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.878000E-03 |
| Normal-VS-Type2 PRCC |
5.796700E-03 |
| Normal-VS-KIRP CIMP |
1.53445999999668E-05 |
| Normal-VS-Unclassified PRCC |
1.561590E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.775200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.12280000000598E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
3.009200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.96169969157722E-10 |
| Type2 PRCC-VS-Unclassified PRCC |
7.109000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.47740000420316E-08 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.562400E-03 |
| Normal-vs-N1 |
7.221800E-04 |
| Normal-vs-N2 |
2.483000E-01 |
| N0-vs-N1 |
8.933900E-02 |
| N0-vs-N2 |
1.663640E-01 |
| N1-vs-N2 |
6.032600E-01 |
|
|
